financetom
Business
financetom
/
Business
/
Update: Market Chatter: Bakkt Holdings Exploring Potential Sale, Breakup
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Market Chatter: Bakkt Holdings Exploring Potential Sale, Breakup
Jun 7, 2024 10:07 AM

12:47 PM EDT, 06/07/2024 (MT Newswires) -- (Updates with additional details, attempts to reach the company for comment, and recent stock move.)

Bakkt Holdings ( BKKT/WS ) is mulling a potential sale amid a spike in crypto-related takeover activity, Bloomberg reported, citing people familiar with the matter.

The company is working with a financial advisor to evaluate strategic alternatives, which include a breakup, the report said.

Bakkt ( BKKT/WS ) has not yet made any final decision and might decide to remain independent, it said.

A representative for the company declined Bloomberg's request for comment.

Bakkt ( BKKT/WS ) did not immediately respond to MT Newswires' request for comment.

Shares of the company were up 9.5% in recent trading.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 21.36, Change: +1.86, Percent Change: +9.54

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Acadia to stop trials of antipsychotic drug after it fails schizophrenia study
Acadia to stop trials of antipsychotic drug after it fails schizophrenia study
Mar 11, 2024
March 11 (Reuters) - Acadia Pharmaceuticals ( ACAD ) said on Monday it does not plan to conduct further clinical trials of its antipsychotic drug, pimavanserin, after it failed to improve negative symptoms of schizophrenia in a late-stage study. Shares of the California-based company fell 16% in extended trading. The decision comes after two failed attempts to secure regulatory approval...
Walgreens settles New York charges it inflated prices of infant formula
Walgreens settles New York charges it inflated prices of infant formula
Mar 11, 2024
NEW YORK (Reuters) - Walgreens has settled charges by New York Attorney General Letitia James that the pharmacy chain grossly inflated prices on at least 20 infant formula products in 2022 after a recall by Abbott Labs led to a nationwide shortage. Walgreens did not admit or deny wrongdoing in entering an assurance of discontinuance dated March 7 and made...
Atlassian Insider Sold Shares Worth $1,717,897, According to a Recent SEC Filing
Atlassian Insider Sold Shares Worth $1,717,897, According to a Recent SEC Filing
Mar 11, 2024
05:26 PM EDT, 03/11/2024 (MT Newswires) -- Michael Cannon-Brookes, 10% Owner, Director, Co-CEO, Co-Founder, on March 08, 2024, sold 8,241 shares in Atlassian ( TEAM ) for $1,717,897. Following the Form 4 filing with the SEC, Cannon-Brookes has control over a total of 115,374 shares of the company, with 115,374 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218024002541/xslF345X03/primarydocument.xml Price: 215.82, Change: +0.19, Percent...
BRIEF-Assure Holdings Enters Into Agreement To Sell Certain Of Its Assets To MPOWERHealth
BRIEF-Assure Holdings Enters Into Agreement To Sell Certain Of Its Assets To MPOWERHealth
Mar 11, 2024
March 11 (Reuters) - Assure Holdings Corp ( IONM ): * ASSURE HOLDINGS ENTERS INTO AGREEMENT TO SELL CERTAIN OF ITS ASSETS TO MPOWERHEALTH * ASSURE HOLDINGS CORP ( IONM ): TO SELL CERTAIN ASSETS OF ITS IONM BUSINESS TO MPOWERHEALTH FOR UP TO $4.5 MILLION Source text for Eikon: Further company coverage: ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved